With GLP-1s, microdosing usually means taking smaller amounts than the FDA has approved
VA testing GLP-1 treatment for alcohol use disorder (NewsNation) The Department of Veterans Affairs is launching a clinical trial to test whether semaglutide, a drug best known for treating diabetes and obesity, can help veterans with alcohol use disorder
The results of both animal and cellular studies have demonstrated that in the context of hyperglycemia, the hearts capacity to utilize glucose is diminished, which in turn promotes oxidative stress and inflammation in myocardial cells
The mechanism for increased accumulation of anions and therefore high AG acidosis results from alterations in the gamma glutamyl pathway
For people managing nausea, early satiety, or busy schedules on GLP-1 therapy, that messaging is understandably appealing